Ophthotech Corporation (OPHT) Reports Second Quarter 2014 Financial Results And Provides Business Update
8/6/2014 9:24:19 AM
Ophthotech Corporation (Nasdaq:OPHT) today provided an update on the Company’s business and announced financial results for the second quarter ended June 30, 2014.
•In May 2014, the Company entered into an ex-US licensing and commercialization agreement with Novartis Pharma AG focused on the treatment of wet age-related macular degeneration (AMD).
Help employers find you! Check out all the jobs and post your resume.
comments powered by